Assertio (ASRT)
Search documents
Assertio (ASRT) - 2021 Q2 - Earnings Call Transcript
2021-08-12 23:07
Spectrum Pharmaceuticals, Inc. (SPPI) Q2 2021 Results Conference Call August 12, 2021 4:30 PM ET Company Participants Joe Turgeon – President and Chief Executive Officer Kurt Gustafson – Chief Financial Officer Francois Lebel – Chief Medical Officer Conference Call Participants Maury Raycroft – Jefferies Alethia Young – Cantor Charles Zhu – Guggenheim Securities Ren Benjamin – JMP Securities Mayank Mamtani – B. Riley Securities Operator Good day, and thank you for standing by. Welcome to the Spectrum Pharma ...
Assertio (ASRT) - 2021 Q1 - Earnings Call Transcript
2021-05-14 02:18
Spectrum Pharmaceuticals, Inc. (SPPI) Q1 2021 Earnings Conference Call May 13, 2021 4:30 PM ET Company Participants Kurt Gustafson - Chief Financial Officer Joe Turgeon - President and Chief Executive Officer Francois Lebel - Chief Medical Officer Conference Call Participants Maury Raycroft - Jefferies Ed White - H.C. Wainwright Ren Benjamin - JMP Securities Charles Zhu - Guggenheim Securities Mayank Mamtani - B. Riley Operator Good afternoon, ladies and gentlemen and welcome to the Spectrum Pharmaceuticals ...
Assertio (ASRT) - 2020 Q4 - Earnings Call Transcript
2021-03-31 00:22
Spectrum Pharmaceuticals, Inc. (SPPI) Q4 2020 Earnings Conference Call March 30, 2021 4:30 PM ET Company Participants Kurt Gustafson - Chief Financial Officer Joe Turgeon - President and CEO Dr. François Lebel - Chief Medical Officer Tom Riga - Chief Operating Officer Conference Call Participants Maury Raycroft - Jefferies Emilia Falcetti - Cantor Fitzgerald Ed White - H.C. Wainwright Sahil Kazmi - B. Riley Securities Reni Benjamin - JMP Securities Operator Ladies and gentlemen, thank you for standing by. A ...
Assertio (ASRT) - 2020 Q3 - Quarterly Report
2020-11-06 17:49
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER 001-39294 ASSERTIO HOLDINGS, INC. (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER) Delaware 85-0598378 (STATE OR OTHER JURISDICTION O ...